[8-Arginine]vasopressin, [8-arginine]vasotocin, oxytocin and oxypressin, the 'ring' derivatives pressinamide and tocinamide, and the extended-chain analogues Pro-Arg-Val- [8-arginine]vasopressin and [8-arginine]vasopressinoyl-Ala-Met-Ala-NH2, were synthesized by the solid-phase method and purified by sequential gel filtration on Sephadex G-15 in 50% acetic acid and 0.2M-acetic acid. Controlled oxidation of the thiol groups of the reduced peptides obtained after deprotection with sodium in liquid ammonia gave rise to products that depended on the length of the peptide chain: (i) nonapeptides gave monomer and dimer species, (ii) hexapeptides produced mixtures containing higher polymers, and (iii) dodecapeptides gave predominantly monomer with some dimerized material. The evidence suggests that the presence of the acyclic tail tripeptide in the nonapeptide hormones induces a conformation in the preceding hexapeptide that favours the formation of an intramolecular disulphide bond. For [8-argininelvasopressin, intramolecular disulphide-bond formation is enhanced by extension of the peptide chain from either the N-or the C-terminus. The possible significance of these studies to neurohypophysial hormone-prohormone relationships is discussed.
[8-argininelvasopressin, intramolecular disulphide-bond formation is enhanced by extension of the peptide chain from either the N-or the C-terminus. The possible significance of these studies to neurohypophysial hormone-prohormone relationships is discussed.
The formation of an intramolecular disulphide bond occurs at some stage during the biosynthesis of the neurohypophysial hormones, and presumably takes place in an environment that ensures intramolecular alignment of the thiol groups so that intermolecular disulphide bonds are not formed. During the chemical synthesis of neurohypophysial hormones, both intra-and inter-molecular disulphidebond formation are observed after oxidation of the reduced peptides, suggesting that the hormones Abbreviations used: abbreviations for amino acids and protecting groups are those recommended by the IUPAC-ILJB Commission on Biochemical Nomenclature (1972); Boc, t-butyloxycarbonyl. Synthetic analogues of neurohypophysial hormones: themselves do not represent an 'efficient' environment for intramolecular disulphide-bond formation. The possibility exists that these hormones are biosynthesized in the form of prohormones, which, when released from the ribosomes, are conformationally predisposed to spontaneous and efficient intramolecular disulphide-bond formation.
An index of the precyclic conformation of a given neurohypophysial-hormone analogue may be obtained by determining the degree of difficulty with which its intramolecular disulphide bond is formed, as reflected in the ratio of monomer to polymer(s) obtained after controlled.oxidation of the reduced peptide. By using the appropriate analogues, this approach can give information on the relative p C pressinamide, Cys-Tyr-Phe-Gln-Asn-Cys-NH2; I~~~~~~~~~~~~~~~~~~~~I oxypressin, Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Pro-Arg-Val-[Arg8]vasopressin, Pro-Arg-Val-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2;
[Arg8]vasopressinoyl-Ala-Met-Ala-NH2, Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-Ala-Met-Ala-NH2- (Moore et al., 1978) .
Methods
All the required hormones and derivatives were synthesized by the Merrifield (1963 Merrifield ( , 1964 method and were deblocked and purified by described procedures (Manning, 1968; Manning et al., 1968) . Pharmacological potencies were determined by rat uterus (Heller & Lederis, 1959) and rat pressor (Dekanski, 1952) (Gisin, 1973) and were subsequently acetylated (Stewart & Young, 1969 Deprotection and purification of peptides. After completion of the required cycle procedure, the dry peptide-resin was ammonolysed in 150ml of methanol saturated with NH3 (at 0°C) for 2 days in a sealed flask at room temperature (23°C). The mixture was evaporated in vacuo through soda-lime and the residue dissolved in dimethylformamide (lOOml). The resin was removed by filtration and dimethylformamide removed in vacuo. The residue was triturated with methanol (150ml), dried and recrystallized from acetic acid/methanol. The fully protected peptide amide (50-150mg) was dissolved in anhydrous liquid NH3 (100-200ml) and the boiling solution titrated with sodium (by dipping a sodium-filled 1 ml pipette into the solution) until a light-blue colour persisted. After 15s the colour was discharged with 2 drops of dry acetic acid and the ammonia allowed to evaporate through a soda-lime guard tube. The product was dissolved in 0.2 % acetic acid (3 ml/mg of protected peptide), the pH adjusted to 7 with 2M-NH3 soln. and the solution titrated with 0.01 M-potassium ferricyanide until a yellow colour persisted. After stirring for 20min, AG-3X4A resin (Bio-Rad) was added and the solution stirred for a further 20min. The resin was removed by filtration, and the filtrate adjusted to pH 4 with acetic acid and freeze-dried. The residue was dissolved in 50% (v/v) acetic acid (2ml) and chromatographed on a column (90cmx2.5cm) of Sephadex G-15 eluted with 50% acetic acid at a flow rate of 8-lOml/h. Fractions containing monomer material (fractions were selected for purity rather than yield) were pooled and freezedried. The residue was dissolved in 0.2M-acetic acid (2 ml) and re-run through the Sephadex G-1 5 column eluted with 0.2 M-acetic acid at a flow rate of 12-15 ml/ h. Fractions containing the required peptide were pooled and freeze-dried.
The ratio of monomer to polymer(s) was determined for each peptide after the first Sephadex G-1 5 chromatography step from the areas under the peaks. data and pharmacological potencies of the peptides are given in Table 2 .
The results of a systematic study of the products obtained after oxidation of the reduced peptides are exemplified in Fig. 1 (Fig. 2) . These findings suggest that, when dealing with small peptides, it would be more accurate to relate elution volume to log (molecular diameter) (i.e. the length of the longest axis of the peptide) rather than molecular weight.
Discussion
The synthesis of neurohypophysial hormones usually requires the oxidative formation of the disulphide bridge as a final chemical step. This reaction can theoretically produce not only the required monomer (intramolecular disulphide) but also dimers and higher polymers arising from the formation of intermolecular disulphides. To obtain a pure product the unwanted polymers must be removed, and this has traditionally been carried out by countercurrent distribution (Schroder & Lubke, 1966) , gel-exclusion chromatography , partition chromatography (Yamashiro, 1964) or ion-exchange chromatography (Kasafirek et al., 1966) . Although chromatographic data have often not been reported in detail, it is clear from the available evidence that the oxidation step in the synthesis of neurohypophysial hormones produces only monomer and dimer species . Furthermore, analogues of neurohypophysial hormones in which single-or multiple-site amino acid replacements have been made produce essentially the same situation, although small amounts of higher polymers have been observed with some analogues (M. Manning, personal communication) .
In the present study, the products obtained after controlled oxidation of the thiol groups of the hexapeptide 'ring' derivatives of the neurohypophysial hormones were found to differ considerably from those of the hormones themselves. Thus both pressinamide and tocinamide produced substantial quantities of trimers, tetramers, pentamers etc., which were not observed with the nonapeptide hormones (Fig. 1) . Since there is no precedent for the existence of polymeric species held together by non-covalent binding forces under the extreme denaturing conditions used in the Sephadex G-15 chromatography step, i.e. 50% acetic acid, these products arise from the formation of intermolecular disulphide bonds. [This conclusion has been substantiated by demonstrating that (i) similar elution profiles are obtained when these peptides are chromatographed on a Sephadex G-15 column equilibrated with 8M-urea, (ii) reduced [Arg8]vasopressin is eluted from Sephadex G-15 in 50% acetic acid essentially as a single peak in a position immediately preceding that of the cyclic monomer, and (iii) reduction and reoxidation of [Arg8]vasopressin dimer material results in the formation of monomer and dimer.] This indicates that the presence of the acyclic tripeptide in the nonaVol. 173 peptide hormones induces a conformation in the preceding hexapeptide portion of the molecule that favours the formation of the intramolecular disulphide bond, whereas in the absence of the tripeptide tail oxidation of the thiol groups produces a more random interaction leading to a greater percentage of intermolecular disulphide bonds. It is also possible that the acyclic tripeptide may impose a steric restraint on intermolecular thiol interaction, although this seems unlikely if [Arg8]vasopressin assumes a conformation in solution that is similar to that proposed for oxytocin in dimethyl sulphoxide (Urry & Walter, 1971) .
A possible factor contributing to a precyclic conformational state that favours the formation of an intramolecular disulphide bond is the presence of the Cys6-Pro7 bond, which, owing to the rigid structure of the cyclic proline moiety, would create a bend in this region of the molecule. However, for the synthesis of an analogue of [Lys8]vasopressin in which Pro7 was replaced by Val (Boissonas et al., 1963) , and which was obtained from the fully protected peptide precursor by procedures that were essentially the same as those described here, no polymer formation was reported and the required compound was obtained from the fully protected peptide in 48% yield. This seems to indicate that Pro7 is not the sole determining factor in orienting the pre-cyclic conformation of neurohypophysial hormones. Other factors arising from the interactions of the acyclic tripeptide with the ring portion of the molecule, e.g. the proposed hydrogen-bonding between the side-chain -C=O of Asn5 and the -NH of Leu8 in oxytocin (Urry & Walter, 1971) , may also contribute to the pre-cyclic conformational state.
These findings provide independent evidence in support of the suggestion made by Walter (1972) , based on n.m.r.-spectroscopy studies on oxytocin and [Lys8] vasopressin, that the tripeptide seems to exert some influence on the conformation of the ring of neurohypophysial hormones. In retrospect, these studies show that before disulphide formation the acyclic tripeptide may orientate the conformation of the preceding hexapeptide in such a way as to favour the intramolecular disulphide linkage, but do not show that the ring, once formed, remains under the influence of the tripeptide. However, a continued interaction in the completed cyclic structure would be strongly implicated.
It is perhaps not surprising that the presence of the complete nonapeptide structure of the neurohypophysial hormones is required to give rise to a conformation in solution that brings the thiol groups of the reduced peptide into close proximity with one another. A similar situation has been proposed for the hypophysiotropic principle somatostatin, which contains a disulphide bond maintaining a cyclic dodecapeptide structure. On the basis of the observation that [Cys(Me)3] somatostatin, an analogue unable to form the disulphide bond, has a potency of 4 % of that of the native hormone, and full intrinsic activity, it has been suggested that intramolecular associations other than the disulphide bond maintain the molecule in a conformation that can be recognized by somatostatin receptors (Vale et al., 1976 (Fig. 1) . Similarly, elongation of the peptide chain from the C-terminus, as in [Arg8]vasopressinoyl-Ala-Met-Ala-NH2, confers favourable intramolecular-disulphide-bond-forming properties to the open-chain molecule (Fig. 1) . These observations result from the imposition of steric and/or conformational restraints on the molecule due to the increased length of the peptide backbone. This phenomenon could be influenced by the nature of the 'extra' amino acids, although several analogues of the neurohypophysial hormones in which the peptide chain was extended from the N-terminus apparently gave low amounts of dimers under similar conditions of synthesis (this deduction is inferred from Fig. 1 (Moore et al., 1977 (Urry & Walter, 1971) and assuming some similarity in conformation between reduced and oxidized forms of the peptides, steric-hindrance effects should not have a major influence in thiol-group interactions.
The choice of amino acids added to the N-and Ctermini respectively of [Arg8]vasopressin was dictated by the amino acid sequence of bovine neurophysin II (Schlesinger et al., 1975; Wuu & Crumm, 1976) . In ox, neurophysin II is the specific carrier protein of [Arg8]vasopressin (Dean et al., 1968) and may at some stage in the biosynthesis of [Arg8]vasopressin form part of a putative prohormone (Hope & Pickup, 1974) . These experiments were carried out in an attempt to obtain evidence that might differentiate between two possibilities concerning the covalent attachment of [Arg8]vasopressin in its putative prohormone: via either (i) the N-terminus or (ii) the C-terminus of [Arg8]vasopressin. In retrospect, the evidence favours the alternative possibility that the neurohypophysial hormone may exist in a more central location in the sequence of a precursor molecule, i.e. covalently attached via both the N-and the C-termini. However, the formation of the disulphide bond was carried out under nonphysiological conditions, and interpretations should be treated with due caution.
Further experimentation on disulphide stability with extended-chain analogues of neurohypophysial hormones may give further insight into the resolution of the prohormone-hormone relationship. Indeed, until better techniques are available for the isolation of hormone precursors, comparisons of the structural and conformational stabilities of synthetic prohormones with their respective hormones may, in general, provide an alternative approach to this problem.
